Quotas, and Anti-discrimination Policies Relating to Autism in the EU: Scoping Review and Policy Mapping in Germany, France, Netherlands, United Kingdom, Slovakia, Poland, and Romania.


Journal

Autism research : official journal of the International Society for Autism Research
ISSN: 1939-3806
Titre abrégé: Autism Res
Pays: United States
ID NLM: 101461858

Informations de publication

Date de publication:
08 2020
Historique:
received: 17 12 2019
revised: 09 04 2020
accepted: 23 04 2020
pubmed: 23 5 2020
medline: 10 4 2021
entrez: 23 5 2020
Statut: ppublish

Résumé

The low employment rates of persons with Autism Spectrum Conditions in the European Union (EU) are partly due to discrimination. Member States have taken different approaches to increase the employment rate in the recent decades, including quota and anti-discrimination legislation, however, the implications for people with autism are unknown. The purpose of this scoping review was to provide a comprehensive overview of the history of these employment policies, from seven EU Member States (Germany, France, the Netherlands, the United Kingdom [prior to exit], Slovakia, Poland, and Romania), exploring the interdependence on international and EU policies, using a path dependency analysis. The results indicate that internationally a shift in focus has taken place in the direction of anti-discrimination law, though employment quotas remained in place in six out of the seven Member States as a means to address employment of people with disability in combination with the new anti-discrimination laws. LAY SUMMARY: Discrimination is partially responsible for the low employment of people with autism. Several approaches have been taken in recent years, such as anti-discrimination laws and setting a mandatory number of people with disabilities that need to be employed. This study finds that, internationally and in the European Union, the focus was initially on the use of quotas and gradually moved to anti-discrimination, with both being used simultaneously. Autism Res 2020, 13: 1397-1417. © 2020 The Authors. Autism Research published by International Society for Autism Research published by Wiley Periodicals, Inc.

Identifiants

pubmed: 32441457
doi: 10.1002/aur.2315
pmc: PMC7496597
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1397-1417

Informations de copyright

© 2020 The Authors. Autism Research published by International Society for Autism Research published by Wiley Periodicals, Inc.

Références

Mol Autism. 2019 Dec 9;10:43
pubmed: 31827745
J Appl Psychol. 2016 Mar;101(3):430-49
pubmed: 26595753
Occup Environ Med. 2014 Oct;71(10):730-6
pubmed: 24556535
Int J Soc Psychiatry. 2012 Jan;58(1):62-8
pubmed: 21088037
Autism Res. 2009 Apr;2(2):109-18
pubmed: 19455645
Lancet. 2014 Mar 8;383(9920):896-910
pubmed: 24074734
Autism. 2008 Jul;12(4):403-14
pubmed: 18579647
J Autism Dev Disord. 2005 Jun;35(3):351-60
pubmed: 16119476
J Autism Dev Disord. 2008 Apr;38(4):739-47
pubmed: 17764027
Mol Autism. 2018 Jul 31;9:42
pubmed: 30083306
Implement Sci. 2010 Sep 20;5:69
pubmed: 20854677
Br J Psychiatry. 2016 Mar;208(3):232-8
pubmed: 26541693
Autism. 2015 Feb;19(2):158-67
pubmed: 24443331
Mol Autism. 2019 Dec 11;10:44
pubmed: 31867091
J Child Psychol Psychiatry. 2007 Nov;48(11):1102-10
pubmed: 17995486
Res Synth Methods. 2014 Dec;5(4):371-85
pubmed: 26052958
J Child Psychol Psychiatry. 2004 Feb;45(2):212-29
pubmed: 14982237
J Autism Dev Disord. 2010 Mar;40(3):352-7
pubmed: 19838782
J Am Acad Child Adolesc Psychiatry. 2013 Sep;52(9):931-9
pubmed: 23972695
Pediatrics. 2012 Jun;129(6):1042-9
pubmed: 22585766
Pol Przegl Chir. 1952 Sep-Oct;24(5):641-2
pubmed: 13013870
Eur J Public Health. 2015 Aug;25(4):662-7
pubmed: 25417939
J Am Acad Child Adolesc Psychiatry. 2017 Jun;56(6):466-474
pubmed: 28545751
BMC Public Health. 2014 Dec 22;14:1310
pubmed: 25535401
J Am Acad Child Adolesc Psychiatry. 2013 Jun;52(6):572-81.e1
pubmed: 23702446
Eur J Health Law. 2007 Nov;14(3):281-98
pubmed: 18348362
Disabil Rehabil. 2003 Jun 3-17;25(11-12):572-6
pubmed: 12959330
PLoS One. 2016 Jan 14;11(1):e0147040
pubmed: 26766183
Crisis. 2017 Jul;38(4):237-246
pubmed: 28468556
J Health Soc Behav. 1995 Sep;36(3):230-43
pubmed: 7594356
PLoS One. 2018 Aug 30;13(8):e0202336
pubmed: 30161146
MMWR Surveill Summ. 2018 Apr 27;67(6):1-23
pubmed: 29701730

Auteurs

Danielle Bunt (D)

Department of International Health, School CAPHRI Care and Public Health Research Institute, Faculty of Health Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands.

Robin van Kessel (R)

Department of International Health, School CAPHRI Care and Public Health Research Institute, Faculty of Health Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands.

Rosa A Hoekstra (RA)

Department of Psychology, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.

Katarzyna Czabanowska (K)

Department of International Health, School CAPHRI Care and Public Health Research Institute, Faculty of Health Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands.
Department of Health Policy Management, Faculty of Health Care, Institute of Public Health, Jagiellonian University, Krakow, Poland.
National Institute of Public Health, Warsaw, Poland.

Carol Brayne (C)

Institute of Public Health, University of Cambridge, Cambridge, UK.

Simon Baron-Cohen (S)

Autism Research Centre, Department of Psychiatry, University of Cambridge, Cambridge, UK.

Andres Roman-Urrestarazu (A)

Department of International Health, School CAPHRI Care and Public Health Research Institute, Faculty of Health Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands.
Institute of Public Health, University of Cambridge, Cambridge, UK.
Autism Research Centre, Department of Psychiatry, University of Cambridge, Cambridge, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH